| Ytd | 26.28% | |
| 1y | -17.23% |
| Open | 2.01 | Prev Close | 1.99 | Low | 1.91 | High | 2.01 | Mkt Cap | 52.37M |
| Vol | 432.54K | Avg Vol | 764.11K | EPS | -0.96 | P/E | -2.05 | Forward P/E | -2.23 |
| Beta | 0.97 | Short Ratio | 18.08 | Inst. Own | 24.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.53 | 200-d Avg | 1.55 | 1yr Est | 19.83 |
INMB News
Commercial-Ready Manufacturing Now Supports Planned Phase 3 Confirmation Trial, and US, EU and UK Re
Commercial-Ready Manufacturing Now Supports Planned Phase 3 Confirmation Trial, and US, EU and UK Re
The Department of Defense–funded study; entitled: "Inhibition of Soluble TNF Mitigates Traumatic
The study points to soluble TNF as a key biological link between head injury and Alzheimer's disease
Advanced MRI analyses showed early treatment-related changes in white matter myelin integrity and co
Submission advances a key element of the Company’s global intellectual property strategy for its nex
INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a late-stage biotechnology company focused on
MHRA minutes from May 12 pre-MAA Scientific Advice meeting confirm agreement across all questions co
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua
During Thursday, 166 stocks hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday